- Home
- Browse
- Damon Runyon Cancer Research Foundation
- Damon Runyon Cancer Research Foundation — Award Selection Committees
Damon Runyon Cancer Research Foundation — Award Selection Committees
- Deadline
- Rolling
- Check the funder's page for current deadlines
- Award ceiling
- —
- Awards
- —
- Posted
- —
Summary
Award Selection Committees | Damon Runyon Cancer Research Foundation Skip to main content SEARCH Award Selection Committees The Damon Runyon Cancer Research Foundation’s reputation in the scientific community is unsurpassed, in part due to the high standards upheld by its award selection committees. […]
The rest of this announcement — free with an account
- →The full announcement text, not the first two sentences
- →The scoring framework for this mechanism — we have not extracted per-criterion detail for this specific announcement
- →Whether you are eligible — career stage, institution type, and the windows that close before the deadline does
- →What similar funded projects received, from 219,000 past awards
No card required. Browsing and your first match are free.
More from Damon Runyon Cancer Research Foundation
See all →Also in cancer
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for projects to expand, improve, or transform the utility of mammalian cancer and tumor models for translational research.
3 review criteria on fileAssay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for identification of small molecules that function to elucidate the biology of disease as chemical probes or function as agonists or antagonists of disease target(s) for therapy or immunotherapy.
3 review criteria on fileIntegrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to support extramural research to investigate and mitigate challenges facing clinical assay development and subsequent analytical validation due to preanalytical variability in tumor tissue biopsies, blood biospecimens utilized as liquid…
3 review criteria on fileOfficial announcement: https://www.damonrunyon.org/for-scientists/award-selection-committeesSource: funder_program_scrape. Always confirm dates with the funder.